Skip to content
lifestyle.hoteleguide.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cue Biopharma, Inc.
Cue Biopharma Announces 1-for-30 Reverse Stock Split
April 22, 2026
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
April 15, 2026
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
April 8, 2026
Cue Biopharma Announces CEO Transition
March 27, 2026
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
March 16, 2026
←
Previous Page
1
2